Advice to Primary Care Providers: Recognizing MIS-C

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

In the final part of their interview with HCPLive®, Dongngan Truong, MD, University of Utah Health and Intermountain Primary Children’s Hospital, and Jane Newburger, MD, Boston Children’s Hospital, spoke on the importance for primary care providers to recognize multisystem inflammatory syndrome in children (MIS-C) and related symptoms.

“One of the most important things about MIS-C is recognition,” said Truong. “Obviously, given the overlap of symptoms of MIS-C with other things, the differential or what doctors think about might be causing symptoms has to be broad.”

Nevertheless, she encouraged providers to be cognizant of the possibly, especially in children who have previous been diagnosed with coronavirus disease 2019 (COVID-19).

She underscored the important role of close follow-up, utilizing the right labs during the diagnosis process, and understanding when to seek referral to a center that can offer proper treatment and care.

“For a busy pediatric practice with kids who are sick and have fever, this can be a needle in a haystack,” Newburger acknowledged. “But it really makes a difference to get somebody to care quickly.”

Part of the recognition process, of course, is staying informed with the definitions of MIS-C, which include knowing the symptoms and presentations typically associated with the condition.

As time and research will hopefully tell, the long-term outcomes of the newly discovered syndrome and at-risk subpopulations will become better understood.

Related Videos
Esther Ellen Freeman, MD, PhD: How COVID-19 Is Affecting Skin Differently in 2023
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
Berdazimer Gel Provides Complete Molluscum Clearance in 30% of Patients in 12 Weeks
Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
Megan Noe, MD, MPH: Navigating COVID-19 Vaccines, Boosters with the Immunocompromised
Megan Noe, MD, MPH: Navigating Vaccines, COVID-19 Boosters with Dermatology Patients
John Harris, MD, PhD: Year 1 of Ruxolitinib Cream for Vitiligo
Caitlin Treuting: Medical Photography Grows in Pediatric Dermatology
Alberto Pappo, MD: Why Pediatric Melanoma Diagnosis Is In Flux
Related Content
© 2023 MJH Life Sciences

All rights reserved.